Paper40667402
Predictive Value of High-Sensitivity CRP Level on the No-Reflow Phenomenon in STEMI Patients.
Krasniqi X and 4 others. Cardiol Res Pract, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Predictive Value of High-Sensitivity CRP Level on the No-Reflow Phenomenon in STEMI Patients. Papers, record 40667402. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40667402
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Predictive Value of High-Sensitivity CRP Level on the No-Reflow Phenomenon in STEMI Patients.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28886621 | 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). | Eur Heart J | 2018 | https://conductscience.org/library/papers/28886621 | PubMed |
| 2 | 23111142 | Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. | Am J Cardiol | 2013 | https://conductscience.org/library/papers/23111142 | PubMed |
| 3 | 37171284 | Association between apelin-12 and creatine kinase-MB, depending on success of reperfusion in STEMI patients. | Cardiovasc J Afr | 2024 | https://conductscience.org/library/papers/37171284 | PubMed |
| 4 | 31275641 | Novel Molecular Targets Participating in Myocardial Ischemia-Reperfusion Injury and Cardioprotection. | Cardiol Res Pract | 2019 | https://conductscience.org/library/papers/31275641 | PubMed |
| 5 | 35456326 | "No-Reflow" Phenomenon: A Contemporary Review. | J Clin Med | 2022 | https://conductscience.org/library/papers/35456326 | PubMed |
| 6 | 19327529 | Cyclophosphamide protects against myocardial ischemia/reperfusion injury in rats: one of the therapeutic targets is high sensitivity C-reactive protein. | J Thorac Cardiovasc Surg | 2009 | https://conductscience.org/library/papers/19327529 | PubMed |
| 7 | 37832116 | High CRP-albumin ratio is associated high thrombus burden in patients with newly diagnosed STEMI. | Medicine (Baltimore) | 2023 | https://conductscience.org/library/papers/37832116 | PubMed |
| 8 | 26616729 | The no-reflow phenomenon: State of the art. | Arch Cardiovasc Dis | 2015 | https://conductscience.org/library/papers/26616729 | PubMed |
| 9 | 33593616 | Predictive Value of CAR for In-Hospital Mortality in Patients with COVID-19 Pneumonia: A Retrospective Cohort Study. | Arch Med Res | 2021 | https://conductscience.org/library/papers/33593616 | PubMed |
| 10 | 37622654 | 2023 ESC Guidelines for the management of acute coronary syndromes. | Eur Heart J | 2023 | https://conductscience.org/library/papers/37622654 | PubMed |
| 11 | 37025078 | The Role of Artificial Intelligence in Coronary Artery Disease and Atrial Fibrillation | Balkan Med J | 2023 | https://conductscience.org/library/papers/37025078 | PubMed |
| 12 | 22764104 | Mitochondrial ROS production and subsequent ERK phosphorylation are necessary for temperature preconditioning of isolated ventricular myocytes. | Cell Death Dis | 2012 | https://conductscience.org/library/papers/22764104 | PubMed |
| 13 | 39263796 | Comparison of inflammatory markers for the prediction of atrial fibrillation recurrence following cryoablation. | Biomark Med | 2024 | https://conductscience.org/library/papers/39263796 | PubMed |
| 14 | 37623467 | Risk Factors of Suboptimal Coronary Blood Flow after a Percutaneous Coronary Intervention in Patients with Acute Anterior Wall Myocardial Infarction. | J Pers Med | 2023 | https://conductscience.org/library/papers/37623467 | PubMed |
| 15 | 29694958 | Current Mechanistic Concepts in Ischemia and Reperfusion Injury. | Cell Physiol Biochem | 2018 | https://conductscience.org/library/papers/29694958 | PubMed |
| 16 | 30571511 | Fourth Universal Definition of Myocardial Infarction (2018). | Circulation | 2018 | https://conductscience.org/library/papers/30571511 | PubMed |
| 17 | 19631649 | CRP regulates the expression and activity of tissue factor as well as tissue factor pathway inhibitor via NF-kappaB and ERK 1/2 MAPK pathway. | FEBS Lett | 2009 | https://conductscience.org/library/papers/19631649 | PubMed |
| 18 | 16624260 | C-reactive protein in atherosclerosis: A causal factor? | Cardiovasc Res | 2006 | https://conductscience.org/library/papers/16624260 | PubMed |
| 19 | 38661580 | Relationship between the Fibrinogen/Albumin Ratio and Microvascular Perfusion in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevated Myocardial Infarction: A Prospective Study. | Arq Bras Cardiol | 2023 | https://conductscience.org/library/papers/38661580 | PubMed |
| 20 | 25832424 | C-reactive protein stimulates RAGE expression in human coronary artery endothelial cells in vitro via ROS generation and ERK/NF-κB activation. | Acta Pharmacol Sin | 2015 | https://conductscience.org/library/papers/25832424 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42428482 | Association between remnant cholesterol inflammation Index and in-hospital New-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42428482 | PubMed |
| 42351811 | Inflammation-Based C-Reactive Protein-to-Albumin Ratio for No-Reflow Prediction in STEMI. | Biomedicines | 2026 | https://conductscience.org/library/papers/42351811 | PubMed |
| 41682744 | Admission EASIX Score Predicts Coronary No-Reflow and In-Hospital Mortality in STEMI Patients Undergoing Primary PCI. | J Clin Med | 2026 | https://conductscience.org/library/papers/41682744 | PubMed |
| 41598248 | Predictive Value of Apelin-36 for No-Reflow Phenomenon in STEMI Patients. | Life (Basel) | 2026 | https://conductscience.org/library/papers/41598248 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CMPK1 | 51727 | PubTator's text mining | https://conductscience.org/library/genes/51727 | NCBI Gene |
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40667402
GET https://conductscience.org/api/papers/v1/40667402/references?page=2